| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-04-18 |
4 |
D |
$9.69 |
$60,136 |
D/D |
(6,206) |
457,162 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-04-16 |
4 |
D |
$17.08 |
$106,152 |
D/D |
(6,215) |
423,633 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-03-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,750) |
429,848 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-12-20 |
4 |
OE |
$0.99 |
$7,128 |
D/D |
7,200 |
416,505 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-01-16 |
4 |
AS |
$12.00 |
$89,868 |
D/D |
(7,489) |
456,812 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2009-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,025 |
465,440 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-06-08 |
4 |
AS |
$20.36 |
$185,276 |
D/D |
(9,100) |
402,901 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-05-04 |
4 |
AS |
$8.00 |
$79,460 |
D/D |
(9,600) |
573,312 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-05-26 |
4 |
AS |
$11.00 |
$110,000 |
D/D |
(10,000) |
552,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-03 |
4/A |
AS |
$15.60 |
$157,029 |
D/D |
(10,000) |
618,412 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-07-06 |
4 |
AS |
$12.65 |
$127,276 |
D/D |
(10,000) |
582,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-09-01 |
4 |
AS |
$15.90 |
$159,469 |
D/D |
(10,000) |
562,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-10-03 |
4 |
AS |
$13.12 |
$132,978 |
D/D |
(10,000) |
452,812 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-12 |
4 |
OE |
$7.41 |
$74,863 |
D/D |
10,103 |
501,031 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,198 |
367,782 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-02-18 |
4 |
A |
$15.37 |
$160,617 |
D/D |
10,450 |
475,586 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,473 |
412,379 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-05-09 |
4 |
AS |
$9.50 |
$100,230 |
D/D |
(10,500) |
562,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2005-06-16 |
4 |
AS |
$17.00 |
$178,500 |
D/D |
(10,500) |
536,312 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2008-12-17 |
4 |
AS |
$12.02 |
$126,270 |
D/D |
(10,505) |
466,307 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
426,667 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-09-16 |
4 |
AS |
$15.07 |
$167,277 |
D/D |
(11,100) |
330,605 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2006-05-05 |
4/A |
AS |
$15.85 |
$239,241 |
D/D |
(15,000) |
602,812 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2010-08-03 |
4 |
AS |
$22.07 |
$333,610 |
D/D |
(15,116) |
366,874 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-07-05 |
4 |
AS |
$20.35 |
$323,565 |
D/D |
(15,900) |
387,001 |
0 |
- |
|
173 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
